Cytek® Biosciences, Inc. ('Cytek Biosciences” or 'Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the third quarter ended September 30, 2025.
The study showcases an innovative and effective approach for large-scale genomic research of individual cells and viral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback